drugset / Trial / NCT00771199

An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain

NCT00771199 ↗

Phase 4 Completed 14 enrolled Janssen-Cilag Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate safety/tolerability and clinical utility of low-dose transdermal therapeutic system (TTS \[medicated adhesive pad that is placed on the skin to deliver a timed-release dose of medication through the skin into the bloodstream\]) - fentanyl in Taiwan participants with cancer pain. Secondly, to demonstrate the dropout rate that will be decreased by initiating therapy with12 microgram per hour (mcg/hr) instead of with 25 mcg/h.

Timeline

Start
2008-10-01
Primary completion
2008-11-26
Completion
2008-11-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 12 ug Other

Indications

No indication recorded.